mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.2 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.2 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |